CHANGES OF BONE MINERAL DENSITY DURING FOUR-YEAR RITUXIMAB AND METHOTREXATE THERAPY IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS
Objective: to estimate the changes of bone mineral density (BMD) at the femoral neck and lumbar spine during fouryear combination therapy with rituximab (RTM) and methotrexate (MT) in postmenopausal women with rheumatoid arthritis (RA).Subjects and methods. 79 postmenopausal women with a document...
Main Authors: | T. A. Raskina, M. V. Koroleva, O. S. Malyshenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2016-12-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2295 |
Similar Items
-
Time course of bone mineral density changes during 4-year rituximab therapy in postmenopausal women with rheumatoid arthritis
by: T. A. Raskina, et al.
Published: (2015-09-01) -
Prevalence and risk factors of osteoporosis in postmenopausal women with rheumatoid arthritis: a brief report
by: Aghaei M, et al.
Published: (2012-10-01) -
Quality of life in patients with rheumatoid arthritis during rituximab therapy
by: Tatiana Alekseyevna Raskina, et al.
Published: (2013-06-01) -
Quality of life in patients with rheumatoid arthritis during rituximab therapy
by: Tatiana Alekseyevna Raskina, et al.
Published: (2013-06-01) -
Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01)